82 related articles for article (PubMed ID: 20678909)
1. Perfluorinated carboxylic acids inhibit cyclooxygenase pathway more potently than 12-lipoxygenase pathway in rat platelets.
Sakuma S; Fujii Y; Abe M; Arakawa Y; Fujimoto Y
Prostaglandins Leukot Essent Fatty Acids; 2010; 83(4-6):225-8. PubMed ID: 20678909
[TBL] [Abstract][Full Text] [Related]
2. Monochloramine potently inhibits arachidonic acid metabolism in rat platelets.
Fujimoto Y; Ikeda M; Sakuma S
Biochem Biophys Res Commun; 2006 May; 344(1):140-5. PubMed ID: 16615995
[TBL] [Abstract][Full Text] [Related]
3. High density lipoprotein inhibits platelet 12-lipoxygenase activity.
Fujimoto Y; Tsunomori M; Muta E; Yamamoto T; Nishida H; Sakuma S; Fujita T
Res Commun Mol Pathol Pharmacol; 1994 Sep; 85(3):355-8. PubMed ID: 7827811
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the effects of nitric oxide and peroxynitrite on the 12-lipoxygenase and cyclooxygenase metabolism of arachidonic acid in rabbit platelets.
Fujimoto Y; Tagano S; Ogawa K; Sakuma S; Fujita T
Prostaglandins Leukot Essent Fatty Acids; 1998 Aug; 59(2):95-100. PubMed ID: 9774172
[TBL] [Abstract][Full Text] [Related]
5. Metabolism of endogenous arachidonic acid in weakly activated platelets. Absence of leukocyte cooperative products in whole blood.
Guichardant M; Petit F; Lagarde M
Eicosanoids; 1989; 2(2):117-21. PubMed ID: 2516743
[TBL] [Abstract][Full Text] [Related]
6. Isomers of trans fatty acids modify the activity of platelet 12-P lipoxygenase and cyclooxygenase/thromboxane synthase.
Stachowska E; DoĊegowska B; Olszewska M; Gutowska I; Chlubek D
Nutrition; 2004 Jun; 20(6):570-1. PubMed ID: 15165621
[TBL] [Abstract][Full Text] [Related]
7. Ceramide elevates 12-hydroxyeicosatetraenoic acid levels and upregulates 12-lipoxygenase in rat primary hippocampal cell cultures containing predominantly astrocytes.
Prasad VV; Nithipatikom K; Harder DR
Neurochem Int; 2008 Dec; 53(6-8):220-9. PubMed ID: 18680775
[TBL] [Abstract][Full Text] [Related]
8. Platelet 12-lipoxygenase activation via glycoprotein VI: involvement of multiple signaling pathways in agonist control of H(P)ETE synthesis.
Coffey MJ; Jarvis GE; Gibbins JM; Coles B; Barrett NE; Wylie OR; O'Donnell VB
Circ Res; 2004 Jun; 94(12):1598-605. PubMed ID: 15142951
[TBL] [Abstract][Full Text] [Related]
9. The effect of substance P on the arachidonate cascade of rat platelets.
Kis B; Mezei Z; Gecse A; Telegdy G
Acta Physiol Hung; 1997-1998; 85(2):89-97. PubMed ID: 9706302
[TBL] [Abstract][Full Text] [Related]
10. Effects of endocrine disruptors on arachidonic acid metabolism in rabbit platelets.
Fujimoto Y; Sakuma S; Nishiwaki Y; Ikeda M; Fujita T
Toxicol Appl Pharmacol; 2003 Jun; 189(2):96-9. PubMed ID: 12781627
[TBL] [Abstract][Full Text] [Related]
11. Tetrahydrobiopterin attenuates modulation of platelet 12-lipoxygenase and cyclooxygenase activities by nitric oxide.
Fujimoto Y; Sakuma S; Iba Y; Sasaki T; Fujita T
Nitric Oxide; 2001 Feb; 5(1):77-81. PubMed ID: 11178940
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of proliferation of PC3 cells by the branched-chain fatty acid, 12-methyltetradecanoic acid, is associated with inhibition of 5-lipoxygenase.
Yang P; Collin P; Madden T; Chan D; Sweeney-Gotsch B; McConkey D; Newman RA
Prostate; 2003 Jun; 55(4):281-91. PubMed ID: 12712407
[TBL] [Abstract][Full Text] [Related]
13. Rofecoxib [Vioxx, MK-0966; 4-(4'-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles.
Chan CC; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Ford-Hutchinson AW; Forrest MJ; Gauthier JY; Gordon R; Gresser M; Guay J; Kargman S; Kennedy B; Leblanc Y; Leger S; Mancini J; O'Neill GP; Ouellet M; Patrick D; Percival MD; Perrier H; Prasit P; Rodger I
J Pharmacol Exp Ther; 1999 Aug; 290(2):551-60. PubMed ID: 10411562
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of lipoxygenase of rat dental pulp and human platelets by phenolic dental medicaments.
Dohi T; Anamura S; Okamoto H; Tsujimoto A
Dent Jpn (Tokyo); 1990; 27(1):45-9. PubMed ID: 2129162
[TBL] [Abstract][Full Text] [Related]
15. A unique pool of free arachidonate serves as substrate for both cyclooxygenase and lipoxygenase in platelets.
Chevy F; Wolf C; Colard O
Lipids; 1991 Dec; 26(12):1080-5. PubMed ID: 1819690
[TBL] [Abstract][Full Text] [Related]
16. Short-chain fatty acids alter tight junction permeability in intestinal monolayer cells via lipoxygenase activation.
Ohata A; Usami M; Miyoshi M
Nutrition; 2005; 21(7-8):838-47. PubMed ID: 15975492
[TBL] [Abstract][Full Text] [Related]
17. Sphingomyelin inhibits platelet 12-lipoxygenase activity.
Fujimoto Y; Sakuma S; Tsunomori M; Sumiya T; Fujita T
Eur J Pharmacol; 1999 Aug; 378(2):233-6. PubMed ID: 10478636
[TBL] [Abstract][Full Text] [Related]
18. Baicalein induction of hydroxyl radical formation via 12-lipoxygenase in human platelets: an ESR study.
Chou DS; Lee JJ; Hsiao G; Hsieh CY; Tsai YJ; Chen TF; Sheu JR
J Agric Food Chem; 2007 Feb; 55(3):649-55. PubMed ID: 17263456
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of prostaglandin H synthase and activation of 12-lipoxygenase by 8,11,14,17-eicosatetraenoic acid in human endothelial cells and platelets.
Croset M; Bordet JC; Lagarde M
Biochem Pharmacol; 1999 Mar; 57(6):631-8. PubMed ID: 10037447
[TBL] [Abstract][Full Text] [Related]
20. Captopril as a modifier of the arachidonate cascade of rat platelets.
Gecse A; Telegdy G
Agents Actions Suppl; 1992; 38 ( Pt 3)():201-8. PubMed ID: 1462859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
